Analysis of hematopoietic stem cell transplant engraftment: Use of loss or gain of microsatellite alleles to identify residual hematopoietic malignancy

Ming-Tseh Lin, Li Hui Tseng, Katie Beierl, Shuko Harada, Michael J. Hafez, James Eshleman, Christopher Gocke

Research output: Contribution to journalArticle

Abstract

Polymorphic short tandem repeat (STR), or microsatellite, loci have been widely used to analyze chimerism status after allogeneic hematopoietic stem cell transplantation. The presence of a patient's DNA, as identified by STR analysis, may indicate residual or recurrent malignant disease or may represent normal hematopoiesis of patient origin. The ratio of patient-derived to donor-derived alleles is used to calculate the relative amount of patient cells (both benign and malignant) to donor cells. STRs on chromosomes known to be gained or lost in a patient's tumor are generally ignored because it is difficult to perform meaningful calculations of mixed chimerism. However, in this study, we present evidence that STR loci on gained or lost chromosomes are useful in distinguishing the benign or malignant nature of chimeric DNA. In the peripheral blood or bone marrow of 4 hematopoietic stem cell transplantation patients with leukemia or lymphoma, we identified tumor DNA on the basis of STR loci showing copy number alteration. We propose that a targeted evaluation of STR loci showing altered copy number in posttransplant chimerism analysis can provide evidence of residual cancer cells.

Original languageEnglish (US)
Pages (from-to)194-202
Number of pages9
JournalDiagnostic Molecular Pathology
Volume20
Issue number4
DOIs
StatePublished - Dec 2011
Externally publishedYes

Fingerprint

Hematologic Neoplasms
Hematopoietic Stem Cells
Microsatellite Repeats
Alleles
Transplants
Chimerism
Hematopoietic Stem Cell Transplantation
DNA
Chromosomes
Tissue Donors
Hematopoiesis
Residual Neoplasm
Lymphoma
Neoplasms
Leukemia
Bone Marrow

Keywords

  • allogeneic hematopoietic stem cell transplantation
  • chimerism
  • leukemia relapse
  • microsatellite
  • Short tandem repeat

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cell Biology
  • Molecular Biology

Cite this

Analysis of hematopoietic stem cell transplant engraftment : Use of loss or gain of microsatellite alleles to identify residual hematopoietic malignancy. / Lin, Ming-Tseh; Tseng, Li Hui; Beierl, Katie; Harada, Shuko; Hafez, Michael J.; Eshleman, James; Gocke, Christopher.

In: Diagnostic Molecular Pathology, Vol. 20, No. 4, 12.2011, p. 194-202.

Research output: Contribution to journalArticle

@article{b9e0a7fed92340a6ab0394e8996621c6,
title = "Analysis of hematopoietic stem cell transplant engraftment: Use of loss or gain of microsatellite alleles to identify residual hematopoietic malignancy",
abstract = "Polymorphic short tandem repeat (STR), or microsatellite, loci have been widely used to analyze chimerism status after allogeneic hematopoietic stem cell transplantation. The presence of a patient's DNA, as identified by STR analysis, may indicate residual or recurrent malignant disease or may represent normal hematopoiesis of patient origin. The ratio of patient-derived to donor-derived alleles is used to calculate the relative amount of patient cells (both benign and malignant) to donor cells. STRs on chromosomes known to be gained or lost in a patient's tumor are generally ignored because it is difficult to perform meaningful calculations of mixed chimerism. However, in this study, we present evidence that STR loci on gained or lost chromosomes are useful in distinguishing the benign or malignant nature of chimeric DNA. In the peripheral blood or bone marrow of 4 hematopoietic stem cell transplantation patients with leukemia or lymphoma, we identified tumor DNA on the basis of STR loci showing copy number alteration. We propose that a targeted evaluation of STR loci showing altered copy number in posttransplant chimerism analysis can provide evidence of residual cancer cells.",
keywords = "allogeneic hematopoietic stem cell transplantation, chimerism, leukemia relapse, microsatellite, Short tandem repeat",
author = "Ming-Tseh Lin and Tseng, {Li Hui} and Katie Beierl and Shuko Harada and Hafez, {Michael J.} and James Eshleman and Christopher Gocke",
year = "2011",
month = "12",
doi = "10.1097/PDM.0b013e31821dac16",
language = "English (US)",
volume = "20",
pages = "194--202",
journal = "Diagnostic Molecular Pathology",
issn = "1052-9551",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Analysis of hematopoietic stem cell transplant engraftment

T2 - Use of loss or gain of microsatellite alleles to identify residual hematopoietic malignancy

AU - Lin, Ming-Tseh

AU - Tseng, Li Hui

AU - Beierl, Katie

AU - Harada, Shuko

AU - Hafez, Michael J.

AU - Eshleman, James

AU - Gocke, Christopher

PY - 2011/12

Y1 - 2011/12

N2 - Polymorphic short tandem repeat (STR), or microsatellite, loci have been widely used to analyze chimerism status after allogeneic hematopoietic stem cell transplantation. The presence of a patient's DNA, as identified by STR analysis, may indicate residual or recurrent malignant disease or may represent normal hematopoiesis of patient origin. The ratio of patient-derived to donor-derived alleles is used to calculate the relative amount of patient cells (both benign and malignant) to donor cells. STRs on chromosomes known to be gained or lost in a patient's tumor are generally ignored because it is difficult to perform meaningful calculations of mixed chimerism. However, in this study, we present evidence that STR loci on gained or lost chromosomes are useful in distinguishing the benign or malignant nature of chimeric DNA. In the peripheral blood or bone marrow of 4 hematopoietic stem cell transplantation patients with leukemia or lymphoma, we identified tumor DNA on the basis of STR loci showing copy number alteration. We propose that a targeted evaluation of STR loci showing altered copy number in posttransplant chimerism analysis can provide evidence of residual cancer cells.

AB - Polymorphic short tandem repeat (STR), or microsatellite, loci have been widely used to analyze chimerism status after allogeneic hematopoietic stem cell transplantation. The presence of a patient's DNA, as identified by STR analysis, may indicate residual or recurrent malignant disease or may represent normal hematopoiesis of patient origin. The ratio of patient-derived to donor-derived alleles is used to calculate the relative amount of patient cells (both benign and malignant) to donor cells. STRs on chromosomes known to be gained or lost in a patient's tumor are generally ignored because it is difficult to perform meaningful calculations of mixed chimerism. However, in this study, we present evidence that STR loci on gained or lost chromosomes are useful in distinguishing the benign or malignant nature of chimeric DNA. In the peripheral blood or bone marrow of 4 hematopoietic stem cell transplantation patients with leukemia or lymphoma, we identified tumor DNA on the basis of STR loci showing copy number alteration. We propose that a targeted evaluation of STR loci showing altered copy number in posttransplant chimerism analysis can provide evidence of residual cancer cells.

KW - allogeneic hematopoietic stem cell transplantation

KW - chimerism

KW - leukemia relapse

KW - microsatellite

KW - Short tandem repeat

UR - http://www.scopus.com/inward/record.url?scp=81855180897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81855180897&partnerID=8YFLogxK

U2 - 10.1097/PDM.0b013e31821dac16

DO - 10.1097/PDM.0b013e31821dac16

M3 - Article

C2 - 22089346

AN - SCOPUS:81855180897

VL - 20

SP - 194

EP - 202

JO - Diagnostic Molecular Pathology

JF - Diagnostic Molecular Pathology

SN - 1052-9551

IS - 4

ER -